Jeil Pharmaceutical Co.,Ltd 271980.KS Stock
Jeil Pharmaceutical Co.,Ltd Price Chart
Jeil Pharmaceutical Co.,Ltd 271980.KS Financial and Trading Overview
Jeil Pharmaceutical Co.,Ltd stock price | 16980 KRW |
Previous Close | 18860 KRW |
Open | 18970 KRW |
Bid | 18540 KRW x 0 |
Ask | 18800 KRW x 0 |
Day's Range | 18870 - 19150 KRW |
52 Week Range | 15900 - 27500 KRW |
Volume | 7.35K KRW |
Avg. Volume | 52.62K KRW |
Market Cap | 274.96B KRW |
Beta (5Y Monthly) | 1.24726 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | 50 (0.26%) |
Ex-Dividend Date | December 28, 2022 |
1y Target Est | N/A |
271980.KS Valuation Measures
Enterprise Value | 323.73B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.37497807 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.441 |
Enterprise Value/EBITDA | 21.008 |
Trading Information
Jeil Pharmaceutical Co.,Ltd Stock Price History
Beta (5Y Monthly) | 1.24726 |
52-Week Change | -11.037% |
S&P500 52-Week Change | 20.43% |
52 Week High | 27500 KRW |
52 Week Low | 15900 KRW |
50-Day Moving Average | 19399 KRW |
200-Day Moving Average | 19363.9 KRW |
271980.KS Share Statistics
Avg. Volume (3 month) | 52.62K KRW |
Avg. Daily Volume (10-Days) | 23.94K KRW |
Shares Outstanding | 14.57M |
Float | 5.42M |
Short Ratio | N/A |
% Held by Insiders | 62.26% |
% Held by Institutions | 1.96% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | 20.00% |
Payout Ratio | 0.2058 |
Last Split Factor | 1.4:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0.48% |
Operating Margin (ttm) | 0.86% |
Gross Margin | 23.80% |
EBITDA Margin | 2.10% |
Management Effectiveness
Return on Assets (ttm) | 0.86% |
Return on Equity (ttm) | 2.33% |
Income Statement
Revenue (ttm) | 733.28B KRW |
Revenue Per Share (ttm) | 50323.04 KRW |
Quarterly Revenue Growth (yoy) | 6.09% |
Gross Profit (ttm) | N/A |
EBITDA | 15.41B KRW |
Net Income Avi to Common (ttm) | 3.53B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 25.59B KRW |
Total Cash Per Share (mrq) | 1756.48 KRW |
Total Debt (mrq) | 62.46B KRW |
Total Debt/Equity (mrq) | 35.09 KRW |
Current Ratio (mrq) | 1.165 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | -28763009024 KRW |
Levered Free Cash Flow (ttm) | -20702920704 KRW |
Profile of Jeil Pharmaceutical Co.,Ltd
Country | South Korea |
State | N/A |
City | Seoul |
Address | 343, Sapyeong-daero |
ZIP | 06543 |
Phone | 82 2 549 7451 |
Website | https://www.jeilpharm.co.kr |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 989 |
Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.
Q&A For Jeil Pharmaceutical Co.,Ltd Stock
What is a current 271980.KS stock price?
Jeil Pharmaceutical Co.,Ltd 271980.KS stock price today per share is 16980 KRW.
How to purchase Jeil Pharmaceutical Co.,Ltd stock?
You can buy 271980.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jeil Pharmaceutical Co.,Ltd?
The stock symbol or ticker of Jeil Pharmaceutical Co.,Ltd is 271980.KS.
Which industry does the Jeil Pharmaceutical Co.,Ltd company belong to?
The Jeil Pharmaceutical Co.,Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Jeil Pharmaceutical Co.,Ltd have in circulation?
The max supply of Jeil Pharmaceutical Co.,Ltd shares is 14.57M.
What is Jeil Pharmaceutical Co.,Ltd Price to Earnings Ratio (PE Ratio)?
Jeil Pharmaceutical Co.,Ltd PE Ratio is now.
What was Jeil Pharmaceutical Co.,Ltd earnings per share over the trailing 12 months (TTM)?
Jeil Pharmaceutical Co.,Ltd EPS is 0 KRW over the trailing 12 months.
Which sector does the Jeil Pharmaceutical Co.,Ltd company belong to?
The Jeil Pharmaceutical Co.,Ltd sector is Healthcare.